Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy.

Autor: Zhao F; Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210012, China., Yang H; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China., Gao Z; Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210012, China., Liu H; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China., Wu P; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China., Li B; School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China., Yu H; Department of Neurology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210012, China., Shao J; Department of Neurology, Wenling First People's Hospital Affiliated to Wenzhou Medical University, Wenling 317500, China.

Publikováno v: Heliyon [Heliyon] 2023 Dec 11; Vol. 10 (1), pp. e23563. Date of Electronic Publication: 2023 Dec 11 (Print Publication: 2024).